Ultragenyx Announces Presentation of Data From a Single Patient Treated With Recombinant Human Beta-Glucuronidase at 10th Annual World Lysosomal Disease Network Symposium

[GlobeNewswire] – NOVATO, Calif. — Ultragenyx Pharmaceutical Inc. , a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, today announced data presentations from a single … more

View todays social media effects on RARE

View the latest stocks trending across Twitter. Click to view dashboard

See who Ultragenyx is hiring next, click here to view